1. Home
  2. GVA vs PTCT Comparison

GVA vs PTCT Comparison

Compare GVA & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Granite Construction Incorporated

GVA

Granite Construction Incorporated

HOLD

Current Price

$146.78

Market Cap

5.3B

Sector

Industrials

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$73.50

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GVA
PTCT
Founded
1922
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
5.7B
IPO Year
1995
2006

Fundamental Metrics

Financial Performance
Metric
GVA
PTCT
Price
$146.78
$73.50
Analyst Decision
Hold
Buy
Analyst Count
3
17
Target Price
$118.33
$80.65
AVG Volume (30 Days)
728.9K
1.2M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
0.42%
N/A
EPS Growth
47.33
264.48
EPS
N/A
N/A
Revenue
$1,762,965,000.00
$264,734,000.00
Revenue This Year
$13.26
N/A
Revenue Next Year
$6.92
$17.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
36.19
52 Week Low
$88.27
$43.18
52 Week High
$145.00
$87.50

Technical Indicators

Market Signals
Indicator
GVA
PTCT
Relative Strength Index (RSI) 66.17 54.83
Support Level $116.73 $73.41
Resistance Level N/A $79.67
Average True Range (ATR) 4.24 2.97
MACD 0.42 0.42
Stochastic Oscillator 92.65 65.23

Price Performance

Historical Comparison
GVA
PTCT

About GVA Granite Construction Incorporated

Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. The company focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, dams, tunnels, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, and rest from Materials segment.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: